Publication | Open Access
A Prospective Study of Human Papillomavirus (HPV) Type 16 DNA Detection by Polymerase Chain Reaction and Its Association with Acquisition and Persistence of Other HPV Types
297
Citations
17
References
2001
Year
Viral DiagnosticsPathologyGynecologyNucleic Acid Amplification TestReal-time Polymerase Chain ReactionCovid-19Cervical Cancer PreventionCancer-associated VirusPolymerase Chain ReactionHuman Papillomavirus VaccinesCervical Cancer Program ManagementPublic HealthMolecular DiagnosticsDiagnostic VirologyHpv TypesCervical Cancer WorldwideDna ReplicationVirologyDna DetectionEpidemiologyVaccinationCervical Cancer ManagementCervical Cancer ScreeningCervical CancerOther Hpv TypesNucleic Acid AmplificationVaccine EfficacyMedicinePrecancerous Lesions
Human papillomavirus (HPV)-16 causes about half the cases of cervical cancer worldwide and is the focus of HPV vaccine development efforts. Systematic data are lacking as to whether the prevention of HPV-16 could affect the equilibrium of infection with other HPV types and thus alter the predicted impact of vaccination on the occurrence of cervical neoplasia. Therefore, the associations of HPV-16 detection with subsequent acquisition of other HPV types and with the persistence of concomitantly detected HPV types were examined prospectively among 1124 initially cytologically normal women. Preexisting HPV-16 was generally associated with an increased risk for subsequent acquisition of other types. HPV-16 did not affect the persistence of concomitant infections, regardless of type. These findings suggest that the prevention or removal of HPV-16 is not likely to promote the risk of infection with other types, a theoretical concern with current vaccination efforts.
| Year | Citations | |
|---|---|---|
Page 1
Page 1